echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > The Safety of 2,7-Di-tert-butylfluorene

    The Safety of 2,7-Di-tert-butylfluorene

    • Last Update: 2023-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    2,7-Di-tert-butylfluorene, also known as 2,7-DTBF, is an organic compound that is commonly used in the chemical industry.
    It is a white solid that is soluble in organic solvents, and it is used as a starting material in the production of a variety of chemical products.


    One of the most important considerations in the use of any chemical is the issue of safety.
    Chemicals must be handled and stored properly in order to prevent accidents and minimize the risk of harm to workers and the environment.
    In this article, we will take a closer look at the safety of 2,7-Di-tert-butylfluorene, and explore the measures that are typically taken to ensure its safe use in the chemical industry.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.